Skip to main content

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Cremer, Miriam	Cleveland Clinic Lerner Com-Cwru United States	Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)	5R01CA266059-04	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Crowder, Sylvia	H. Lee Moffitt Cancer Ctr & Res Inst United States	The MIND-BC Study: MIND diet for Breast cancer Cognition	1R01CA299480-01	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Crowder, Sylvia	H. Lee Moffitt Cancer Ctr & Res Inst United States	The MIND-BC Study: MIND diet for Breast cancer Cognition	1R01CA299480-01	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Curtis, Amarinthia E	Spartanburg Regional Medical Center United States	Upstate Carolina Consortium - Community Oncology Research Program	3UG1CA239762-06S1	Vanessa A. White, M.P.H.
Curtis, Amarinthia E	Spartanburg Regional Medical Center United States	Upstate Carolina Consortium - Community Oncology Research Program	3UG1CA239762-06S1	Vanessa A. White, M.P.H.
Curtius, Kathleen M.	University Of California, San Diego United States	Multiscale modeling of spatiotemporal evolution in Barrett's esophagus	5R01CA270235-03	Asad Umar, D.V.M., Ph.D.
Czerniak, Bogdan A	University Of Tx Md Anderson Can Ctr United States	Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.	1P01CA296429-01A1	Howard L. Parnes, M.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy	1R21CA296516-01	Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy	1R21CA296516-01	Rachel Altshuler, Ph.D.
Daniel-Macdougall, Carrie	University Of Tx Md Anderson Can Ctr United States	Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma	5R01CA291965-02	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-03
Debes, Jose Daniel	University Of Minnesota United States	Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics	1R37CA297814-01	Sidney Fu, M.D.
Delaney, Joe R	Medical University Of South Carolina United States	Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma	1R21CA292343-01A1	Goli Samimi, Ph.D., M.P.H.

News and Events